Filomena Amoroso

Filomena Amoroso

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
FAFilomena Amoroso
Filomena Amoroso
EIEduardo Ibello
Eduardo Ibello
FSFederica Saracino
Federica Saracino
FCFederica Cermola
Federica Cermola
GPGiovanna Ponticelli
Giovanna Ponticelli
CDCristina D'Aniello
Cristina D'Aniello
Small molecules that can modulate or stabilize cell–cell interactions are valuable tools for investigating the impact of collective cell behavior on various biological processes such as development/morphogenesis, tissue regeneration and cancer progression. Recently, we showed that budesonide, a glucocorticoid widely used as an anti-asthmatic drug, is a potent regulator of stem cell pluripotency. Here we tested the effect of different budesonide derivatives and identified CHD-030498 as a more effective analogue of budesonide. CHD-030498 was able to prevent stem cell pluripotency exit in different cell-based models, including embryonic stem-to-mesenchymal transition, spontaneous differentiation and 3D gastruloid development, and at lower doses compared to budesonide.

30 May 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
FAFilomena Amoroso
Filomena Amoroso
EIEduardo Ibello
Eduardo Ibello
FSFederica Saracino
Federica Saracino
FCFederica Cermola
Federica Cermola
GPGiovanna Ponticelli
Giovanna Ponticelli
CDCristina D'Aniello
Cristina D'Aniello
Small molecules that can modulate or stabilize cell-cell interactions are valuable tools for investigating the impact of collective cell behavior on various biological processes such as development/morphogenesis, tissue regeneration and cancer progression. Recently, we showed that budesonide, a glucocorticoid widely used as anti-asthmatic drug, is a potent regulator of stem cell pluripotency. Here we tested the effect of different budesonide derivatives and identified CHD-030498 as a more effective analogue of budesonide. CHD-030498 was able to prevent stem cell pluripotency exit in different cell-based models, including embryonic stem-to-mesenchymal transition, spontaneous differentiation and 3D gastruloid development, and at lower doses compared to budesonide.